CONCERT PHARMACEUTICALS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2017 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Concert Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2017 to Q3 2022.
  • Concert Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $1.9M, a 39.3% decline year-over-year.
  • Concert Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2022 was $8.74M, a 31.5% decline year-over-year.
  • Concert Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.6M, a 13.1% increase from 2020.
  • Concert Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $11.1M, a 7.62% increase from 2019.
  • Concert Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $10.3M, a 10.2% decline from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $8.74M $1.9M -$1.23M -39.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $9.96M $1.96M -$1.29M -39.6% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $11.3M $2.11M -$1.32M -38.5% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $12.6M $2.76M -$174K -5.92% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-03
Q3 2021 $12.7M $3.12M +$229K +7.91% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $12.5M $3.25M +$450K +16% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $12.1M $3.43M +$954K +38.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $11.1M $2.94M +$322K +12.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 $10.8M $2.9M +$475K +19.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $10.3M $2.8M +$442K +18.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $9.87M $2.48M -$452K -15.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $10.3M $2.62M -$51K -1.91% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $10.4M $2.42M -$311K -11.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $10.7M $2.36M -$442K -15.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $11.1M $2.93M -$370K -11.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $11.5M $2.67M -$121K -4.34% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $11.6M $2.73M +$234K +9.37% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $11.4M $2.8M +$1.23M +78.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $10.2M $3.3M +$1.66M +101% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $8.5M $2.79M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 $2.5M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $1.57M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $1.64M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.